[1]
“PROFILE OF INTRANASAL CORTICOSTEROIDS IN ITALY: SAFETY, COST/EFFECTIVENESS, LOCAL AND SYSTEMIC ADVERSE EFFECTS”., EuroMed Bio J, vol. 9, Jan. 2026, doi: 10.3269/1970-5492.2014.9.11.